Anaptysbio (ANAB) Profit After Tax (2016 - 2026)

Anaptysbio has reported Profit After Tax for 11 years, with the latest figure at -$52.9 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 34.47% year-over-year to -$52.9 million; the trailing twelve-month figure through Mar 2026 stood at -$26.8 million (up 80.95% YoY), and the FY2025 full-year result was -$13.2 million, up 90.89% from the prior year.
• Profit After Tax for Q1 2026 stood at -$52.9 million, down from $49.6 million in the prior quarter.
• The five-year high for Profit After Tax was $49.6 million in Q4 2025, with the low at -$52.9 million in Q1 2026.
• Historically, Profit After Tax has averaged -$29.6 million across 5 years, with a median of -$37.3 million in 2023.
• Annual changes were most pronounced in 2022 — Profit After Tax plunged 7488.34% — and 2025, when it jumped 327.75%.
• Anaptysbio's Profit After Tax stood at -$26.4 million in 2022, then slumped by 59.81% to -$42.2 million in 2023, then soared by 48.39% to -$21.8 million in 2024, then jumped by 327.75% to $49.6 million in 2025, then slumped by 206.59% to -$52.9 million in 2026.
• The last three Profit After Tax figures came in at -$52.9 million (Q1 2026), $49.6 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.